The lancet. Gastroenterology & hepatology
Journal
Overview
publication venue for
-
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial..
8.
2023
-
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial..
7.
2022
-
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial..
7.
2022
-
Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA..
6.
2021
-
Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis..
5.
2019
-
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study..
4.
2019
-
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series..
3.
2018
-
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial..
1.
2016
-
Oesophageal manometry with a solid test meal: ready for prime time?.
2.
2017
-
Uncoupler therapy for NAFLD: is flushing a possible harbinger of a safety concern? - Authors' reply.
2024
-
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.
2021
-
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.
2023
-
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
2023
-
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
2022
-
Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium.
2022
-
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO.
2022
Identity
ISO Abbreviation
-
Lancet Gastroenterol Hepatol
Electronic International Standard Serial Number (EISSN)